Skip to content

Clinical trials

Phase 3 Myelodysplastic Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 3 Country / region: United States Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20024
20031
20041
20052
20063
20071
20086
20092
20105
20113
20133
20143
20152
20162
20174
20182
20193
20203
20212
20221
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated12
Active, not recruiting8
Recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene6
M.D. Anderson Cancer Center4
Alliance for Clinical Trials in Oncology3
Astex Pharmaceuticals, Inc.3
Children's Oncology Group3
Medical College of Wisconsin3
St. Jude Children's Research Hospital3
Takeda3
Traws Pharma, Inc.3
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes69
Leukemia, Myeloid, Acute34
Precursor Cell Lymphoblastic Leukemia-Lymphoma26
Leukemia24
Leukemia, Myelomonocytic, Chronic20
Myeloproliferative Disorders19
Lymphoma18
Hodgkin Disease16
Lymphoma, Non-Hodgkin16
Multiple Myeloma14

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.